Monocytes are a widely conserved cell population in vertebrates with important roles in both inflammation and homeostasis. Under both settings, monocytes continuously arise from hematopoietic progenitors in the bone marrow and, on demand, migrate into tissues through the bloodstream. Monocytes are classified into three subsets-classical, intermediate and nonclassical-based on their cell surface expression of CD14 and CD16 in humans and Ly6C, CX 3 CR1 and CCR2 in mice. In tissues, monocytes differentiate further into monocyte-derived macrophages and dendritic cells to mediate innate and adaptive immune responses and maintain tissue homeostasis. Recently, the progenitors that strictly give rise to monocytes were identified in both humans and mice, thereby revealing the monocyte differentiation pathways.
Introduction
In 1910, Artur Pappenheim coined the term 'monocyte' for phagocytic mononuclear cells lacking coarse granules in the blood (1, 2) . Monocytes are a widely conserved cell population found in mammals, birds, amphibians and fish (3) (4) (5) .
Monocytes arise from hematopoietic stem cells (HSCs) via intermediate progenitors (6) and their development is tightly regulated by cytokines and transcription factors (TFs) (7) . In mice, macrophage colony-stimulating factor (M-CSF), also known as colony-stimulating factor 1 (CSF-1), has central roles in monocyte differentiation, proliferation and survival (8) (9) (10) (11) (12) . The receptor for M-CSF, M-CSFR, has two ligands, M-CSF/CSF-1 (13) and IL-34 (14) . IL-34 is particularly important for the development and maintenance of Langerhans cells and microglia, both of which are mainly derived from embryonic progenitors (15) (16) (17) . As critical TFs for monocyte development, purinerich box 1 (PU.1; encoded by SPI1) in conjunction with interferon regulatory factor 8 (IRF8) inhibits the activity of CCAAT/ enhancer-binding protein α (C/EBPα), a regulator for granulocyte development, and conversely induces Krüppel-like factor 4 (Klf4), a major downstream target for the monocyte commitment, thereby promoting monocyte differentiation (18) (19) (20) (21) .
In this review, we focus on monocyte subsets and their differentiation, and discuss the similarities and differences between humans and mice.
Heterogeneity of monocytes

Categorization of monocyte subsets in humans and mice
Under physiological conditions, monocytes represent ~10 and 4% of the white blood cells in the peripheral blood (PB) of humans and mice, respectively. In 1983, human monocyte subsets were isolated for the first time using gradient and counterflow centrifugation (elutriation) methods (22) , which allowed researchers to characterize the subsets, such as by their cell surface markers, including CD14 (a co-receptor of Toll-like receptor 4), and their immunological functions (22) (23) (24) (25) (26) .
Subsequently, human monocytes were subdivided into two populations-CD14 hi CD16
− and CD14 hi CD16 + cellsbased on their expression of CD14 and CD16 (FcγR-III) (27) and their different functions, e.g. phagocytosis and the production of reactive oxygen species and cytokines (28, 29 + (non-classical) monocytes (33) ( Table 1 ). Other surface markers that are differentially expressed on and useful for classifying human monocyte subsets include CD62L, CCR2, CX 3 CR1 and CD43 (34) (35) (36) .
The proportions of classical, intermediate and non-classical monocytes in the circulation are ~85, 5 and 10%, respectively (34) . Notably, classical monocytes sequentially give rise to intermediate and then to non-classical monocytes in vivo and in vitro (34, 37) . The intermediate monocytes consist of at least two populations based on distinct expressions of Tie-2 (Angiopoietin-1 receptor). The Tie-2-expressing monocytes represent about 20% of the intermediate monocytes and promote angiogenesis in tumor and inflammation sites (38, 39 (44) , second by the re-population kinetics of each monocyte subset after monocyte depletion (45) , third by the adoptive transfer of Ly6C + monocytes (44, 46) , fourth by the transplantation of monocyte progenitors (47) and fifth by the analysis of single-cell transcriptomics (42) .
The conversion from Ly6C + to Ly6C − monocytes and the survival of the Ly6C − monocytes require C/EBPβ as a master regulator, which drives the expression of nuclear receptor subfamily 4 group A member 1 (NR4A1) (42, 44, 48, 49) . Consistent with this mechanism, deleting a C/EBPβ-binding enhancer element from the Nr4a1 locus results in the disappearance of Ly6C − monocytes (48 int monocytes, which are at a transitional stage and thus are heterogenous at the single-cell level (42) . The discrepancy between heterogeneous versus homogenous Ly6C + monocytes might be due to the use of different sources of monocytes, i.e. BM versus blood, and is likely to reflect the unique differentiation stages of monocytes in different tissue microenvironments.
Characteristics of human monocyte subsets
Different monocyte subsets have distinct features. For example, the half-lives of human classical, intermediate and non-classical monocytes are ~1.6, ~4 and ~7 days, respectively (34) . Consistent with these differences, in mouse the half-lives of Ly6C hi and Ly6C lo monocytes are ~20 h and 2.2 days, respectively (44) . In this section, we describe the characteristics of monocyte subsets, focusing mostly on the human system.
Since (43, 52) . They are considered to be the human counterpart of mouse Ly6C + monocytes, which rapidly egress the BM and are recruited to sites of inflammation on demand (41) . However, in contrast to human classical monocytes, mouse Ly6C + monocytes produce pro-inflammatory cytokines (6, 31) . CD14 hi CD16 + intermediate monocytes express Fc receptors such as CD64 and CD32, have phagocytic activity and produce massive amounts of pro-inflammatory cytokines such as TNF-α, IL-1β and IL-6 upon in vitro LPS stimulation (31, 43, 53) . This monocyte subset is critically involved in a wide range of inflammatory diseases, such as sepsis, rheumatoid arthritis and asthma (54) . Among the CD14 hi CD16
+ monocytes, the Tie-2 + subpopulation expresses angiogenesis-associated genes and has a pro-angiogenic function; it also promotes angiogenesis in tumors (38, 55, 56 cytokines in response to LPS (32, 43) . This monocyte subset is referred to as 'patrolling monocytes', because the cells exhibit crawling behavior on endothelium and survey the endothelial integrity (43) . Although CD14 lo CD16 + monocytes can be divided into Slan + and Slan − fractions (57), these fractions are indistinguishable by transcriptomic analysis (43) .
Development of human monocytes
Monocytes originate primarily from HSCs via sequential intermediates in the fetal liver (FL) and BM. In mouse, based on the identification of common myeloid progenitors (CMPs) and common lymphoid progenitors (58, 59 ), the dichotomy model was proposed. GMPs and megakaryocyte-erythrocyte progenitors (MEPs) were also reported (58) . Later, human counterparts of these myeloid progenitors were reported (60) , which accelerated the study of human myeloid cell development.
Human myeloid progenitors involved in monocyte differentiation
In 1984, human HSCs and progenitors were found to be enriched in the CD34 + cell population (61) and this feature was later supported by clinical studies using transplantation of CD34 + cells (62) (63) (64) . Within the CD34 + cells, HSCs and multipotent progenitors exist in the CD34 + CD38
− fraction in the BM and umbilical cord blood (UCB) (64, 65) . + cells by additionally using CD135 (FLT3) (65) . Notably, the GMPs appear to include several multipotent and unipotent progenitors, which differentiate into monocytes/macrophages, DCs, granulocytes and/or lymphocytes, implying the heterogeneity of the GMP subset (65) . Indeed, MDPs and granulocyte-MDPs have also been identified within the GMPs (66).
Human monocyte progenitors
Because the lifespans of monocyte subsets are short (34, 44) , their developmental programs and equilibrium must be tightly regulated. In this context, mouse common monocyte progenitors (cMoPs) are identified as lineage marker (Lin)
− cells in the BM and spleen (47) . The cMoPs are derived from MDPs, a progenitor with a binary differentiation potential to monocytes and DCs (67) , and strictly give rise to the monocyte lineage including both Ly6C + and Ly6C − monocytes, and not to any other hematopoietic cells (47) . After transferring cMoPs in vivo, cMoPderived LyC6 hi monocytes appear, peaking at 1-2 days, followed by a Ly6C lo monocyte peak between days 3 and 4, implying that LyC6 hi are converted to Ly6C lo monocytes ( Fig. 1) (47) .
The heterogeneity of human GMPs and identification of mouse cMoPs implied that human cMoPs were present within the GMPs (47, 65) . To identify human cMoPs, we focused on the expression of CD64 (FcγRI) and of CLEC12A (C-type lectin domain family 12 member A), which are both highly expressed on human monocytes and macrophages. Using CD64 and CLEC12A, the human GMPs of the UCB and BM hi nor the CD64 int CLEC12A hi cells had the potential to differentiate into lymphocytes. Thus, we concluded that the former are human cMoPs and the latter are revised GMPs (rGMPs) (Fig. 1) (37) .
In this context, both the human and mouse cMoPs express CD64 and CLEC12A, but only human cMoPs express CD135 (37, 47) . Cross-species analysis using comprehensive gene expression profiling showed common features between the human and mouse cMoPs (37) . Collectively, the conventional GMPs are a mixed population that contains cMoPs, rGMPs and other progenitors.
Human cMoPs give rise to monocytes via monocyte precursors, i.e. pre-monocytes, and the existence of pre-monocytes was previously predicted (68) . In this respect, we also recently found human pre-monocytes (37) . The cell surface marker expression and differentiation potential of the premonocytes are almost the same as those of cMoPs, except for the expression of a stem cell marker CD34 and the colonyforming potential: the pre-monocytes are CD34
− and have no colony-forming activity.
Comparison of the monocyte differentiation pathway between humans and mice
Human rGMPs differentiate into cMoPs and pre-monocytes, whereas human cMoPs give rise to pre-monocytes but not rGMPs ex vivo (37) , suggesting that rGMPs sequentially differentiate into cMoPs, pre-monocytes and monocytes (Fig. 1) .
Since the pre-monocytes are present in the BM but not in PB, monocytes appear to be differentiated in the BM and to egress the BM after birth. Whereas human cMoPs are derived from rGMPs, which produce monocytes and granulocytes but not DCs (37), mouse cMoPs are derived from MDPs (47) . Similar to human rGMPs, the mouse GMPs produce neutrophils and monocytes but not DCs or MDPs (51) . Further analyses of these upstream progenitors are required for the elucidation of the cMoP differentiation pathway. From another perspective, fibrosis-inducing segregated-nucleus-containing atypical monocytes (SatMs) were recently reported (69) . This unique subset originates from GMPs via SatM progenitors in a C/EBPβ-dependent manner. Although the GMPderived Ly6C + monocytes and SatMs share some granulocyte features (51, 69), they appear to be different populations from each other, because SatMs are Ly6C − . Under certain inflammatory conditions in mice, monocytes are also provided from the spleen, which contains a reservoir of monocytes including cMoPs in mice (47, 70) , implying that a similar route might supply monocytes in humans. However, due in part to the limited availability of sample material, it has not yet been shown whether cMoPs exist in the human spleen. Given that monocytes cause a variety of inflammatory diseases and promote cancer development, for clinical applications it is important to clarify the similarities and differences in the monocyte differentiation and supply systems between humans and mice.
Monocyte-derived macrophages and DCs in humans
In 1972, van Furth et al proposed the concept of a 'mononuclear phagocyte system' (71) , in which all tissue-resident macrophages are derived from BM monocytes. However, in 1989, Takahashi et al. (72) suggested that yolk sac (YS)-derived macrophages emerge at the embryonic stage, implying that tissue macrophage differentiation can occur by a route that is independent of BM monocytes. Recent fatetracing studies addressed this question and clearly demonstrated that most tissue-resident macrophages are seeded before birth (44, (73) (74) (75) (76) (77) and are maintained by self-renewal (78) . In this context, some tissue-resident macrophages are replaced by adult circulating monocytes in the intestine (79), dermis (80) , heart (81, 82) and pancreas (83), although they fail to self-maintain (84) and thus a continuous supply of monocytes is required. In addition, FL monocytes, but not BM monocytes, cultured with GM-CSF give rise to macrophages that self-renew for weeks in vitro (85) , suggesting that the self-maintenance capacity is imprinted in monocytes during the prenatal period.
In the human dermis, there are two populations of CD14 + macrophages: non-autofluorescent macrophages and melanin-granule-containing autofluorescent macrophages (86, 87) . In patients with mutations in the TFs GATA2 or IRF8 who lack circulating monocytes, non-autofluorescent macrophages are absent but recover within 30 days after HSC transplantation (88, 89) . On the other hand, a proportion of the autofluorescent macrophages remained and were maintained for at least a year even after BM transplantation (90) . Thus, the non-autofluorescent macrophages are of monocyte origin, whereas the other autofluorescent macrophages are generated independently of monocytes, at least in part. The murine homologs of human non-autofluorescent CD14 + dermal macrophages are CD11b + CD64
+ macrophages, which are also derived from circulating monocytes (87) .
Alveolar macrophages predominantly consist of tissueresident macrophages and exhibit a negligible need to be replaced in mice raised in specific pathogen-free (SPF) conditions (75, 76, 91) . They maintain lung homeostasis by clearing pulmonary surfactant and controlling immune homeostasis (92) . Patients with loss-of-function mutations in GM-CSF receptor, patients with auto-antibodies against GM-CSF and mice lacking GM-CSF or its receptor show alveolar-macrophage deficiency, which leads to pulmonary alveolar proteinosis (PAP) (75, (93) (94) (95) . The main symptoms of PAP are a progressive accumulation of surfactant in alveoli and hypoxemic respiratory failure, which are rescued either by BM transplantation or by Ly6C hi monocyte transfer (95) (96) (97) , suggesting that monocytes are recruited to the lung alveoli, where they further differentiate into functional alveolar macrophages, depending on the niche where they settle.
Human moDCs emerge as CD14 + CD1c + cells in the skin and arthritic synovial fluid in inflammatory diseases and in tumor ascites, and induce pathogenic T h 1 and T h 17 cells (98, 99) . In line with these findings, human cMoP-derived monocytes differentiate into CD14 +
CD1c
+ moDCs ex vivo in the presence of GM-CSF, a representative inflammatory cytokine (37 + cells from macrophages because of their morphological resemblance and prominent capacity to take up apoptotic cells (100, 101) .
There are significantly fewer dermal moDCs in germ-free mice than in SPF mice, suggesting that skin commensals play a role in the moDC differentiation (80) . Given that environmental factors such as pathogens, commensals and inflammation are likely to trigger the recruitment of monocytes and to promote their differentiation into macrophages and moDCs, it is possible that the proportion of BM-monocyte-derived cells in human tissues is higher than that in the tissues of laboratory mice.
Besides macrophages and DCs, osteoclasts are cells that are also primarily derived from monocytes and their progenitors (97, 102) . CD11b -/lo
Ly6C
hi progenitor-like cells, which phenotypically resemble cMoPs (47), show prominent osteoclast-forming activity in the BM of SKG mice (which spontaneously develop arthritis) (97) . IRF8-knockout mice show osteoporosis because IRF8 suppresses osteoclastogenesis by inhibiting nuclear factor of activated T cells c1 (NFATc1) (103), a critical TF for osteoclast differentiation (104) . In this context, silencing of IRF8 mRNA in human CD14 + monocytes enhances osteoclast differentiation ex vivo, showing the conserved role of IRF8 in osteoclastogenesis in humans and mice (104) . On the other hand, an infant who lacks IRF8 function shows normal osteoclast activity (88) . Given that IRF8 is essential for the development of monocytes in humans and mice but not cMoPs, at least in mice (20, 88, 91) , there might be different sources of osteoclast precursors in neonates and adults, e.g. monocyte-dependent and -independent pathways.
Conclusions
Monocytes have a wide range of plasticity that enables them to differentiate dynamically into diverse macrophages including tumor-associated macrophages, DCs and osteoclasts (Fig. 1) . However, questions remain about how the plasticity of monocytes is imprinted during their development and how it is sustained after monocyte commitment. In addition, after heart injury, neonatal monocytes fully repair the heart, whereas adult monocytes induce inflammation and scar formation (105) , implying that epigenetic changes affect monocyte flexibility during life-stage progression. The mechanisms behind these epigenetic changes remain to be explored. In the context of ontogeny and phylogeny, monocytes emerge much later than macrophages (3) (4) (5) , implying that monocytes and macrophages have distinct roles in the body.
Compared to underwater life, organisms that live on land face many more pathogens and have a higher risk of tissue injury. Thus, in land animals, monocytes (and other hematopoietic cells) might have emerged out of immunological necessity. In addition, while the majority of tissue-resident macrophages are seeded at an embryonic stage from the YS (44, (73) (74) (75) (76) (77) , the supply of YS-derived macrophages cannot be expected after birth, particularly when YS-derived macrophages are lost during tissue injury and regeneration. Thus, monocytes replenish the lost macrophages, adapt to various microenvironments and maintain tissue homeostasis. The flexible differentiation capacity of monocytes is probably required for their physiological and urgent replenishment and adaptation.
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